The desire to develop a non-invasive treatment option for treating brain tumours was what pushed Swedish neurosurgeon Dr. Lars Leksell and his colleague to build the first Gamma Knife in 1968. The treatment option received positive reviews from the healthcare providers and patients alike, and soon it became sought-after in treating neurological disorders. Since then, over 700,000 patients have been successfully treated using the Gamma Knife, and today, it remains one of the most technologically advanced instruments in use.

The demand for Gamma Knife instruments is growing steadily the world over, and according to a market research report, the global Gamma Knife market will be worth US$ 411 Mn by 2025. The advantages of Gamma Knife over other invasive treatment have led to increased adoption by clinics and healthcare professionals. Let’s take a brief look at the advantages of Gamma Knife treatment.

Gamma Knife is used to treat metastatic tumours, benign tumours, acoustic neuromas, pituitary adenomas, vascular malformations, and trigeminal neuralgia.

Safe Treatment Option

Gamma Knife treatment has been developed after four decades of clinical research, and as discussed previously, over 700,000 patients have treated effectively through this treatment. Treatment through Gamma Knife does not require any surgery or incision, and a number of patients have benefitted due to this. Gamma Knife treatment is carried out in a single session, and most patients are able to resume their normal routine within a day or two. Owing to these factors, the demand for Gamma Knife instruments is growing steadily around the globe.

Fewer Side Effects

Anaesthesia can cause a range of side effects among patients, especially among the elderly. However, as Gamma Knife treatment does not involve any incision, there is no requirement for administering anaesthesia. Also, the Gamma Knife instrument precisely targets the tumorous cells, with impacting the critical nerve cells. The dose of cobalt-60 photon radiation that each patient receives is customised according to the findings of the MRIs and other tests.

Although Gamma Knife treatment has fewer complications that surgical procedures, there are a few side-effects that have been reported by patients. Swelling in the brain or where the device has been attached can cause headache, nausea, and vomiting. Also, the patient may experience itchiness or hair loss after the treatment.

Gamma Knife versus Cyber Knife

Although Cyber Knife has been hailed as an effective radiosurgical procedure, it lacks the targeted focus that is a hallmark of Gamma Knife market. For procedures that demand a high level of accuracy, Gamma Knife still remains the best treatment option for the patient.

One of the key differences between Cyber Knife and Gamma Knife treatment is the use of a robotic arm in the former. This is done to compensate for the movement of the patient during the procedure. Owing to this, the level of accuracy desired for complicated treatment procedures is not available to the healthcare professionals. In contrast, Gamma Knife treatment immobilizes the patient in a lightweight head frame, diminishing the need for a robotic arm. Owing to this, a high level of accuracy is achieved through this procedure.

As discussed previously, the treatment through Gamma Knife takes just one sitting; on the other hand, Cyber Knife requires a series of multiple treatments, which can last through a period of time. Furthermore, Gamma Knife provides exact MR and CT correlation, which is inherently less accurate in case of Cyber Knife.

Browse Full: "Gamma Knife Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025" Market Research Report at http://www.futuremarketinsights.com/reports/details/gamma-knife-market

Similar Industry Reports

Similar Industry Reports

Gas & Dual-Fuel Injection Systems Market
Coronary Heart Disease Diagnostic Imaging Market

This report covers the coronary heart disease diagnostic imaging market through analysis of market size, revenue forecast, competitive landscape, demand outlook, growth drivers, restraints, imaging pathway shifts, supply-side developments, and strategic growth opportunities.

Gas & Dual-Fuel Injection Systems Market
mRNA Vaccine Formulation Stability and Stress Test Systems Market

This report covers the mRNA vaccine formulation stability and stress test systems market through analysis of market size, market share, revenue forecast, system pricing benchmarks, company positioning, competitive landscape, demand outlook, growth drivers, restraints, technology trends, formulation testing requirements, assay integration, analytical method continuity, end-user adoption, supply chain developments, regulatory and quality expectations, investment opportunities, profitability outlook, and strategic growth opportunities during 2026 to 2036.

Gas & Dual-Fuel Injection Systems Market
Cell Therapy Cryopreservation and Thaw Performance Test Platforms Market

This report covers the cell therapy cryopreservation and thaw performance test platforms market through analysis of market size, market share, revenue forecast, platform segmentation, assay readout trends, cell type demand, preservation format usage, automation level adoption, end-user demand, workflow stage requirements, regional outlook, technology developments, handling standardization needs, method transfer practices, comparability testing, supply chain dynamics, regulatory and quality expectations, investment opportunities, profitability outlook, and strategic growth opportunities during 2026 to 2036.

Gas & Dual-Fuel Injection Systems Market
Gene Editing Off-Target Effect Detection Test Systems Market

The Gene Editing Off-Target Effect Detection Test Systems Market is segmented by Detection Approach (Cell-based Assays, Biochemical Assays, In Silico Tools, Orthogonal Validation), Product Format (Services, Assay Kits, Software, Instruments, Reagents), Workflow Stage (Site Nomination, Site Confirmation, Structural Follow-up, Release Support), Editing Modality (CRISPR-Cas9, Base Editing, Prime Editing, Cas12 Systems, Other Editors), Readout Technology (Amplicon NGS, Short-read WGS, Single-cell DNA, ChIP-seq Workflows, Long-read Sequencing), End User (Biopharma Companies, Academic Laboratories, CROs, CDMOs, Hospitals), Application (IND-enabling Studies, Discovery Screening, Cell Therapy Quality Assessment, In vivo Profiling, Comparability Studies), Deployment (Outsourced Testing, In-house Testing, Hybrid Models), and Region. Forecast for 2026 to 2036.

Gas & Dual-Fuel Injection Systems Market
At-home Blood Collection Kits And Devices Market

This report covers the at-home blood collection kits and devices market through analysis of market size, revenue forecast, competitive landscape, demand outlook, growth drivers, restraints, self-collection workflow trends, regulatory developments, and strategic growth opportunities.